Last-Hope drug offered to advanced colon cancer patients
NCT ID NCT06195514
Summary
This program provided compassionate early access to the drug fruquintinib for adults with advanced colorectal cancer that had stopped responding to all standard treatments. Participants took oral capsules in repeating cycles. The goal was to control the cancer and extend life when no other satisfactory options were available.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.